Assessing the diagnostic test accuracy of natriuretic peptides and ECG in the diagnosis of left ventricular systolic dysfunction: A systematic review and meta-analysis

British Journal of General Practice

Volumn 56, Issue 522, 2006, Pages 48-56

  Davenport, Clare ^a   Cheng, Elaine Yee Lan ^a   Kwok, Yip Tung Tony ^a   Lai, Annie Hiu On ^a   Wakabayashi, Taka ^a   Hyde, Chris ^a   Connock, Martin ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Diagnostic tests; Electrocardiography; Natriuretic peptides; Review; Systematic

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; CLINICAL TRIAL; COHORT ANALYSIS; COST UTILITY ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ELECTROCARDIOGRAM; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; META ANALYSIS; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PROTEIN DETERMINATION; REFERENCE VALUE; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

ADULT; COHORT STUDIES; ELECTROCARDIOGRAPHY; HUMANS; NATRIURETIC PEPTIDE, BRAIN; QUALITY ASSURANCE, HEALTH CARE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 30544438509     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Mair FS, Crowley TS, Bundred P. Prevalence, aetiology and management of heart failure in general practice. Br J Gen Pract 1996; 46: 77-79.
2. Parameshwar J, Shackell MM, Richardson A, et al. Prevalence of heart failure in three general practices in north west London. Br J Gen Pract 1992; 42: 287-289.
3. Wheeldon NM, MacDonald TM, Flucker CJ, et al. Echocardiography in chronic heart failure in the community. Q J Med 1993; 86(1): 17-23.
4. Lamberts H, Brouwer HJ, Mohrs J. Reason for encounter - episode- and process-oriented standard output from the transition project. Amsterdam: Department of General Practice, 1990.
5. Ambrosio GB, Riva L, Casiglia E. Prevalence of congestive heart failure (CHF) in elderly. A survey from a population of Veneto region. Acta Cardiologica 1994; 49: 324-325.
6. Clarke KW, Gray D, Hampton JR. The prevalence of heart failure estimated from prescription data. Br Heart J 1994; 71(Suppl): 33.
7. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cordial 1993; 22(4 Suppl A): 6A-13A.
8. Kannel WB, Kalon Ho, Thorn T. Changing epidemiological features of cardiac failure. Br Heart J 1994; 72(2 Suppl): S3-9.
9. McDonagh TA, Morrison CE, Lawrence A, et al. Symptomatic and asymptomatic left ventricular systolic dysfunction in an urban population. Lancet 1997; 350(9081): 829-833.
10. Davies M, Hobbs F, Davis R, et al. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening Study: a population based study. Lancet 2001; 358: 439-444.
11. Stewart S, Jenkins A, Buchan S, et al. The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail 2002; 4(3): 361-371.
12. Cleland JGF, Cohen-Solal J, Cosin Aguilar J, et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 2002; 360: 1631-1639.
13. Luthi JC, Lund MJ, Sampietro-Colom L, et al. Readmissions and the quality of care in patients hospitalized with heart failure. Int J Qual Health Care 2003; 15(5): 413-421.
14. Fuat A, Hungin AP, Murphy JJ. Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ 2003; 326: 196-202.
15. Mair F. Do GPs underuse ACE inhibitors in heart failure? Prescriber 1996; 7(12): 99-101.
16. Mayor S. Integrate care for heart failure. Medical Interface 1996; May.
17. Khunti K, Hearnshaw H, Baler R, Grimshaw G. Heart failure in primary care: qualitative study of current management and perceived obstacles to evidence-based diagnosis and management by general practitioners. Eur J Heart Fail 2002; 4: 771-777.
18. Naik MM, Diamond G, Pai T, et al. Correspondence of left ventricular ejection fraction determinations from two-dimensional echocardiography, radionuclide angiography and contrast cineangiography. J Am Coll Cardial 1995; 25(4): 937-942.
19. Badgett RG, Lucey CR, Mulrow CD. Can the clinical examination diagnose left sided heart failure in adults? JAMA 1997; 277(21): 1712-1719.
20. Badgett RG, Mulrow CD, Otto P, Ramirez G. How well can the chest radiograph diagnose left ventricular dysfunction? J Gen Intern Med 1996; 11(10): 625-634.
21. Khunti K, Baker R, Grimshaw G. Diagnosis of patients with chronic heart failure in primary care: usefulness of history, examination, and investigations. Br J Gen Pract 2000; 50: 50-54.
22. Cleland JG, Habib F. Assessment and diagnosis of heart failure. JJ Intern Med 1996; 239(4): 317-325.
23. Dargie H, McMurray JJV. Diagnosis and management of heart failure. BMJ 1994; 308: 321-328.
24. Davies M, Gibbs CR, Lipp GYH. ABC of heart failure: investigation. BMJ 2000; 320: 297-300.
25. National Collaborating Centre for Chronic Conditions on behalf of NICE. Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care. Salisbury: Royal College of Physicians, 2003. http://www.rcplondon.ac.uk/pubs/books/chf/heartfailure.pdf (accessed 5 Dec 2005.)
26. Centre for Health Services Research. Evidence-based clinical practice guideline. ACE inhibitors in the primary care management of adults with heart failure. Newcastle upon Tyne: University of Newcastle upon Tyne North of England Evidence Based Guideline Project, 1997. http://www.nelh.nhs.uk/guidelinesdb/html/AFACEHF.HTM (accessed 5 Dec 2005.)
27. Scottish Intercollegiate Guidelines Network. A National Clinical Guideline. Diagnosis and treatment of heart failure due to left ventricular systolic dysfunction. Edinburgh: SIGN, 1999.
28. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation 2001; 104(24): 2996-3007.
29. National Heart Foundation of New Zealand. A guideline for the management of heart failure: health professionals guide. Auckland: National Heart Foundation of New Zealand, 2001. http://www.guideline.gov/summary/ summary.aspx?ss=15&doc_id=3309&nbr=2535 (accessed 5 Dec 2005.)
30. Remme WJ, Swedberg K, Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22: 1527-1560.
31. Ballaglia M, Bucher M, Egger M. The Bayes Library of diagnostic studies and reviews. 2nd edition, 2002. http://www.ispm.unibe.ch/files/fde/261.Bayes_library_handbook.pdf (accessed 5 Dec 2005).
32. British Society of Echocardiography Guidelines. Training in echocardiography. Br Heart J 1994; 71(4 Suppl): 2-5.
33. Sahn DJ, De Maria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
34. Roelandt J, Gibson DG. Recommendations for standardization of measurements from M-mode echocardiograms. Eur Heart J 1980; 1: 375-378.
35. Jaeschke R, Guyatt G, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 1994; 271(5): 389-391.
36. Jaeschke R, Guyatt G, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 1994; 271(9): 703-707.
37. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. 2nd edn. Boston: Little Brown, 1991.
38. Zamora J, Muriel A, Abraira V. Meta-DiSc for Windows: a software package for the meta-analysis of diagnostic tests. Barcelona: XI Cochrane Colloquium, 2003. http://www.hrc.es/investigacion/metadisc_en.htm (accessed 5 Dec 2005.)
39. Deville WL, Buntinx F, Boater LM, et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2002; 2: 9.
40. McGowan J, Cleland JGF. Reliability of reporting left ventricular systolic function by echocardiography: a systematic review of 3 methods. Am Heart J 2003; 146: 388-397.
41. Deeks JJ. Systematic reviews of evaluations of diagnostic and screening tests. In: Chalmers I, Altman DG, Egger M (eds). Systematic reviews in health care. Meta-analysis in context. London: BMJ Books, 2001: 248-282.
42. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21(11): 1539-1558.
43. Mitchell MD. Validation of the summary ROC for diagnostic test meta-analysis: a Monte Carlo simulation. Acad Radiol 2003; 10(1): 25-31.
44. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993; 12(14): 1293-1316.
45. Altman DG. Chapter 14. Practical statistics for medical research. Some common problems in medical research. London: Chapman and Hall, 1991.
46. Alehagen U, Lindstedt G, Eriksson H, Kahlstrom U. Utility of the amino-terminal fragment of pro-brain natriuretic peptide in plasma for the evaluation of cardiac dysfunction in elderly patients in primary health care. Clin Chem 2003; 49(8): 1337-1346.
47. Baker DW, Bahler RC, Fimkelhor RS, Lauer MS. Screening for left ventricular systolic dysfunction among patients with risk factors for heart failure. Am Heart J 2003; 146(4): 736-740.
48. Bettencourt P, Ferreira A, Dias P, et al. Evaluation of brain natriuretic peptide in the diagnosis of heart failure. Cardiology 2000; 93: 19-25.
49. Byrne J, Morton JJ, Metcalfe MJ, Dargie HJ. Baseline Assessment of Plasma Brain Natriuretic Peptide and Simple Clinical Variables Predicting Long-Term Left Ventricular Function Following Acute Myocardial Infarction. Heart 1996; 75(5 Suppl 1): S31.
50. Campbell DJ, Mitchelhill KI, Schlicht SM, Booth RJ. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction. J J Card Fail 2000; 6(2): 130-139.
51. Choy AMJ, Darbar D, Lang CC, et al. Detection of Ventricular Dysfunction after Acute Myocardial Infarction: comparison of clinical, echocardiographic and neurohormonal methods. Br Heart J 1994; 72(1): 16-22.
52. Cosin Aguilar J, Hernandiz Martinez A, et al. Value of NTproBNP concentration in an out-of-hospital adult population. Rev Esp Cordial 2003; 56(3): 236-244.
53. Cowie MR, Struthers AD, Wood DA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997; 350: 1347-1351.
54. Davie AP, Francis CM, Love MP, et al. Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. BMJ 1996; 312: 222.
55. Fox KF, Cowie MR, Wood DA, et al. A Rapid Access Heart Failure Clinic provides a prompt diagnosis and appropriate management of new heart failure presenting in the community. Eur J Heart Fail 2000; 2(4): 423-429.
56. Hobbs FDR, Davis RC, Roaffe AK, et al. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ 2002; 324(7352): 1498-1500.
57. Houghton AR, Sparrow NJ, Toms E, Cowley AJ. Should general practitioners use the electrocardiogram to select patients with suspected heart failure for echocardiography? Int J Cordial 1997; 62: 31-36.
58. Hutcheon SD, Gillespie ND, Struthers AD, McMurdo ME. B-type natriuretic peptide in the diagnosis of cardiac disease in elderly day hospital patients. Age Ageing 2002; 31(4): 295-301.
59. Khandekar S, Bossingham CM, Murphey JJ. Open access echocardiography for suspected heart failure: would a 12 lead electrocardiogram be just as good. Heart 1996; 75(5 Suppl 1): 119.
60. Krishnaswamy P, Lubien E, Clopton P, et al. Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med 2001; 111: 274-279.
61. Kruger S, Filzmaier K, Graf J, et al. QRS prolongation on surface ECG and brain natriuretic peptide as indicators of left ventricular systolic dysfunction. J Intern Med 2004: 255: 206-212.
62. Landray MJ, Lehman R, Arnold I. Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross sectional study. BMJ 2000; 320: 985-986.
63. Lindsay MM, Goodfield NER, Hogg KJ, Dunn FG. Optimising direct access ECHO referral in suspected heart failure. Scott Med J 2000; 45(2): 43-44.
64. Mattleman SJ, Hakki A-Hamid, Iskandran AS, et al. Reliability of bedside evaluation in determining left ventricular function: correlation with left ventricular ejection fraction determined by radionucleide ventriculography. J Am Coll Cardiol 1983; 1(2): 417-420.
65. McClure SJ, Caruana L, Davie AP, et al. Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care. BMJ 1998; 317: 516-519.
66. Mosterd A, de Bruijine MC, Hoes AW, et al. Usefulness of echocardiography in detecting left ventricular dysfunction in population-based studies (The Rotterdam Study). Am J Cardiol 1997; 79: 103-104.
67. Neilson OW, Hansen JF, Hilden J, Svanegaard J. Risk assessment of left ventricular systolic dysfunction in primary care: cross sectional study evaluating a range of diagnostic tests. BMJ 2000; 320: 220-224.
68. Neilson LS, Svanegaard J, Klitgaard NA, Egeblad H. N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnoea. Eur J Heart Fail 2004; 6: 63-70.
69. Richards M, Nicholls MG, Yandle TG, et al. Plasma n-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998; 97: 1921-1929.
70. Rihal CS, Davis KB, Kennedy JW, Gersh BJ. The utility of clinical, electrocardiographic and roentenographic variables in the prediction of left ventricular function. Am J Cardiol 1995; 75: 220-223.
71. Sim V, Hampton D, Phillips C, et al. The use of brain natriuretic peptide as a screening test for left ventricular systolic dysfunction - cost-effectiveness in relation to open access echocardiography. Fam Pract 2003; 20(5): 570-574.
72. Talreja D, Gruver C, Sklenar J, et al. Efficient utilisation of echocardiography for the assessment of left ventricular systolic function. Am Heart J 2000; 139(3): 394-398.
73. Valli N, Georges A, Corcuff JB, et al. Assessment of brain natriuretic peptide in patients with suspected heart failure: comparison with radionuclide ventriculography data. Clin Chim Acta 2001; 306(1-2): 19-26.
74. Wright SP, Doughty RN, Pearl A, et al. Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care. J Am Coll Cardiol 2003; 42(10): 1793-1800.
75. Yamamoto K, Burnett JC, Jougasaki M, et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996; 28: 988-994.
76. Yamamoto K, Burnett J, Bermudez EA, et al. Clinical criteria and biochemical markers of the detection of systolic dysfunction. J Cardiac Failure 2000; 6(3): 194-200.
77. Zaphiriou A, Robb S, Murray-Thomas T, et al. Ruling out heart failure with BNP or NTproBNP: does it work in practice. Results of the UK Natriuretic Peptide Study. Heart 2003; 89(Suppl 1): A49.
78. Alderson P, Green S, Higgins JPT (eds). Cochrane Reviewers' Handbook 4.2.2. [updated March 2004]. http://www.cochrane.org/resources/handbook/hbook.htm (accessed 6 Dec 2005.)
79. Knottnerus JA, van Weel C. General introduction: evaluation of diagnostic procedures. In: Knottnerus JA (ed.). The evidence base of clinical diagnosis. London: BMA books, 2002: 1-16.